Boston Family Office LLC Eli Lilly & CO Transaction History

Boston Family Office LLC

  • $1.39 Billion
  • Q2 2024

A detailed history of Boston Family Office LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Boston Family Office LLC holds 5,567 shares of LLY stock, worth $5.06 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
5,567
Previous 5,587 0.36%
Holding current value
$5.06 Million
Previous $4.35 Million 15.97%
% of portfolio
0.36%
Previous 0.31%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
SELL
$724.87 - $909.04 $14,497 - $18,180
-20 Reduced 0.36%
5,567 $5.04 Million
Q1 2024

May 13, 2024
SELL
$592.2 - $792.28 $213,192 - $285,220
-360 Reduced 6.05%
5,587 $4.35 Million
Q4 2023

Feb 12, 2024
SELL
$525.19 - $619.13 $161,233 - $190,072
-307 Reduced 4.91%
5,947 $3.47 Million
Q3 2023

Nov 13, 2023
SELL
$434.7 - $599.3 $412,095 - $568,136
-948 Reduced 13.16%
6,254 $3.36 Million
Q1 2023

May 10, 2023
SELL
$310.63 - $364.82 $5,591 - $6,566
-18 Reduced 0.25%
7,202 $2.47 Million
Q4 2022

Feb 07, 2023
SELL
$321.55 - $374.67 $10,289 - $11,989
-32 Reduced 0.44%
7,220 $2.64 Million
Q3 2022

Nov 08, 2022
SELL
$296.48 - $337.87 $592,663 - $675,402
-1,999 Reduced 21.61%
7,252 $2.34 Million
Q2 2022

Aug 11, 2022
SELL
$278.73 - $327.27 $41,809 - $49,090
-150 Reduced 1.6%
9,251 $3 Million
Q4 2021

Feb 14, 2022
BUY
$224.85 - $279.04 $28,106 - $34,880
125 Added 1.35%
9,401 $2.6 Million
Q2 2021

Aug 12, 2021
SELL
$180.55 - $233.54 $4,513 - $5,838
-25 Reduced 0.27%
9,276 $2.13 Million
Q1 2021

May 07, 2021
SELL
$164.32 - $212.72 $48,967 - $63,390
-298 Reduced 3.1%
9,301 $1.77 Million
Q4 2020

Feb 16, 2021
SELL
$130.46 - $172.63 $15,133 - $20,025
-116 Reduced 1.19%
9,599 $1.62 Million
Q3 2020

Nov 10, 2020
SELL
$146.22 - $169.13 $1,608 - $1,860
-11 Reduced 0.11%
9,715 $1.44 Million
Q1 2020

May 11, 2020
SELL
$119.05 - $147.35 $5,952 - $7,367
-50 Reduced 0.51%
9,726 $1.35 Million
Q2 2019

Jul 30, 2019
BUY
$110.79 - $129.32 $1,218 - $1,422
11 Added 0.11%
9,776 $1.08 Million
Q1 2019

May 09, 2019
SELL
$111.31 - $131.02 $5,565 - $6,551
-50 Reduced 0.51%
9,765 $1.27 Million
Q4 2018

Feb 12, 2019
SELL
$105.9 - $118.64 $10,590 - $11,864
-100 Reduced 1.01%
9,815 $1.14 Million
Q4 2017

Feb 06, 2018
SELL
$81.94 - $87.89 $54,490 - $58,446
-665 Reduced 6.29%
9,915 $837,000
Q3 2017

Nov 13, 2017
BUY
$77.07 - $85.54 $815,400 - $905,013
10,580
10,580 $905,000

Others Institutions Holding LLY

# of Institutions
3,887
Shares Held
763M
Call Options Held
6.34M
Put Options Held
7.97M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Boston Family Office LLC Portfolio

Follow Boston Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Family Office LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email